Note: Descriptions are shown in the official language in which they were submitted.
CA 02385288 2002-03-20
WO 01/30236 PCT/US00/40785
SOLID-STATE NON-INVASIVE THERMAL CYCLING SPECTROMETER
RELATED APPLICATION
This application claims the benefit of U. S. Patent Application Serial No. :
09/427,178 filed
October 25, 1999.
TECHNICAL FIELD
The present invention relates to an apparatus for inducing transient thermal
gradients
in human or animal tissue, and for obtaining infrared spectra from the tissue
as the thermal
gradient propagates through the tissue. The resulting infrared spectra may
then be used to
determine concentration of substances (analytes) present in the tissue, for
example, glucose.
IS BACKGROUND OF THE INVENTION
Millions of diabetics draw blood daily to determine blood glucose levels.
Substantial
effort has been expended in a search for a non-invasive method of accurately
determining blood
glucose concentrations. To that end, Optiscan Biomedical Corporation of
Alameda,
California, has significantly advanced the state of the art of non-invasive
blood glucose
analysis. In a series of patents and patent applications, Optiscan has defined
the state of the
art for non-invasive blood glucose determination.
The methodologies taught in U.S. Patent Application Serial Nos. 08/820,378 and
09/267,121 may be performed by the apparatuses taught in U.S. Patent
Application Serial Nos.
08/816,723 and 09/265,195, and each of these references is hereby incorporated
by reference.
By way of introduction, objects at temperatures greater than -273.16°C
(absolute zero)
emit infrared energy. Such emissions are often described by Planck's Equation
and referred
to as "black body curves" . Theoretically, a body having an emissivity of 1.0
shows perfect
agreement with Planck's Equation. Advantageously, many objects have emissivity
close to
1Ø In particular, human tissue has emissivity of approximately 0.9 to 0.98.
It is well known
1
CA 02385288 2002-03-20
WO 01!30236 PCT/US00/40785
that infrared emissions from the human body may be closely approximated by
Planck's
Equation and yield black body type emission spectra.
Although the human body emits energy having a distribution that approximates
that
described by Planck's Equation, Planck's Equation does not completely describe
the sum total
of all energy emitted by a human body. Variations from perfect agreement with
Planck's
Equation are caused by selective absorption of radiation by the layers of
tissue and body fluid
in the human body. Thus, layers of tissue and blood or other fluids may
selectively absorb
emitted energy from the deeper layers of the body before that energy can reach
the surface of
the skin. Furthermore, because the deeper layers of the human body are warmer
than the outer
layers, a temperature gradient exists within the body. This causes a further
deviation from
theoretical black body radiation emission.
However, the inventors have determined that, when the above two conditions
exist, a
composition-dependent absorption spectra may be constructed from proper
analysis of the total
energy emitted from the body. For heterogeneous bodies, the composition of
matter may be
IS depth dependent and, conversely, absorption spectra generated from deeper
layers may contain
sufficient composition information to allow accurate determinations of
concentration of the
individual constituents present in the tissue. This is possible when a
temperature gradient
either occurs naturally, or is induced in the body.
The invention taught in U.S. Patent Application Serial No. 08/820,378 ('378)
uses the
naturally occurring body temperature as the source of infrared emissions. As
these infrared
emissions, which have emanated from deeper inside the body, pass through
layers of tissue that
are closer to the surface, certain wavelengths of energy are selectively
absorbed by the
intervening tissue. This selective absorption of signal produces bands of
reduced energy in the
expected emission spectra when the energy finally exits the material under
study. This spectra
is referred to as the absorption spectra of the material.
The invention taught in Patent Application Number 08/816,723 ('723) uses
actively
induced cooling to promote the selective absorption of radiation by causing a
temperature
gradient to propagate to selected layers of tissue, which typically range
between 40 and 250,
below the tissue surface. As explained in the '723 application, absorption
spectra of the tissue
may be measured and the determination of glucose concentration may be made.
An additional technique for determining the concentration of substances
("analytes")
2
CA 02385288 2002-03-20
WO 01/30236 PCT/US00/40785
in a tissue sample is set forth in U.S. Patent Application Serial No.
09\267,121 ('121). The
' 121 application describes a method of measuring infrared emissions emitted
by a tissue sample
subject to a temperature gradient. By detecting emitted signals at selected
wavelengths and
comparing them to carefully selected reference signals, a frequency or a
magnitude or a phase
difference between the reference signal and an analytical signal may be used
to determine
analyte concentration. Furthermore, the method taught in the ' 121 application
teaches the use
of an intermittently or periodically modulated temperature gradient and the
continuing
measurement of frequency, magnitude, or phase differences caused by analyte
absorbance to
determine analyte concentration. Furthermore, the ' 121 application teaches a
method of
correcting for the effects caused by tissue surfaces.
According to U.S. Patent Application Serial No. 08/820,378 ('378), there is
provided
a spectrometer for the non-invasive generation and capture of thermal gradient
spectra from
human or animal tissue. The '378 spectrometer includes an infrared
transmissive thermal mass
for inducing a transient temperature gradient in the tissue by means of
conductive heat transfer
with the tissue, and a cooling means in operative combination with the thermal
mass for
cooling this thermal mass. There is also provided an infrared sensor for
detecting infrared
emissions emanating from the observed tissue as the gradient progresses into
the tissue. Also
included is a data capture means for sampling the output signals received from
the sensor as
the gradient progresses into the tissue. The '723 invention uses a cooled
germanium cylinder
brought into intermittent contact with the test subject's tissue. The
resulting gradients are used
to perform the methodology taught in Application '378. Skin rewarming,
according to this
invention, is accomplished by simply allowing the patient's skin to naturally
rewarm after each
cooling contact. Alternatively, rewarming may be accomplished by an external
heat source in
the form of a second warmer germanium cylinder. U.S. Patent Application Serial
No.
09/265,195 (' 195) provides a "solid-state" apparatus for creating and
measuring the effects of
transient thermal gradients on tissue. The ' 195 application teaches a single
thermal mass
structure ("a thermal mass window") which both heats and cools the tissue and
is capable of
transmitting the absorption spectra generated by the gradient. This allows the
window to
remain in contact with the tissue during the entire time measurements are
made, thereby
improving accuracy and measurement repeatability.
The inventors discovered that by inducing a cyclic temperature gradient
certain
3
CA 02385288 2002-03-20
WO 01/30236 PCT/LTS00/40785
measurement advantages accrue. These advantages are more apparent when a
fairly rapid
cooling/rewarming cycle time (hereinafter referred to as "cycle time") is
used. Cycle times
on the order of 2 Hz are preferred. Existing devices encountered some
difficulties obtaining
the requisite cycle times due to residual heat or cooling remaining in the
thermal mass
structures after heating and cooling steps. Thus, it took excessive time and
energy to cyclically
induce the cooling and heating steps. There is a need for a thermal gradient
device that can
induce temperature gradients more quickly and using less energy. An advantage
of devices
which generate gradients using less energy is that smaller devices may be
constructed.
SUMMARY OF THE INVENTION
According to the principles of the present invention there is provided a solid-
state
device for determining analyte concentrations within sample tissues. The
device generates a
thermal gradient in the tissue and measures infrared radiation spectra to make
determinations
of tissue analyte concentration. The device comprises an infrared transmissive
window
1 S assembly having a plurality of infrared transmissive elements, one of
which being a heating
element, another being an insulating element. The device also has a cooling
element in
operative combination with the insulating element. The device also comprises
an infrared
detector for detecting an infrared radiation spectrum as it passes through
said window
assembly.
An important aspect of the invention is a thermal insulating and impedance
matching
element positioned between the heating and cooling elements. Yet another
embodiment of the
invention enhances the ability of the device to rapidly cycle through the
cooling/rewarming
cycle by including a heat sink in thermal contact with the cooling element.
This effectively
stabilizes the temperature in the device during cycling. This heat stability
is enhanced through
the use of a phase change material.
Other features of the invention are disclosed or apparent in the section
entitled
"DETAILED DESCRIPTION OF THE INVENTION" .
BRIEF DESCRIPTION OF THE DRAWINGS
For a more comprehensive understanding of the present invention, reference is
made
4
CA 02385288 2002-03-20
WO 01/30236 PCT/US00/40785
to the accompanying drawings in the following Detailed Description of the
Invention. In the
drawings
Figure 1 is a schematic depiction of an apparatus constructed in accordance
with the
principles of the present invention;
Figure 2 is a cross-sectional view of a layered window assembly of the present
invention;
Figure 3 is an exploded cross-sectional view of the layered window assembly of
Figure
2;
Figure 4 is a plan view of a heater grid of the present invention;
Figure 5 is a cut-away perspective view of an apparatus illustrating the
principles of the
present invention;
Figure 6 is a graph of a temperature stability curve;
Figure 7 is an exploded perspective view of a detector element of the present
invention.
Reference numbers refer to the same or equivalent parts of the invention
throughout the
IS several figures of the drawings.
DETAILED DESCRIPTION OF THE INVENTION
The present invention relates to the measurement of infrared (IR) radiation
emitted by
heterogenous bodies. In particular, an apparatus for inducing a temperature
gradient in a tissue
sample and measuring the IR radiation spectra emitted from the tissue. The
following
description is presented to enable one of ordinary skill in the art to make
and use the invention
as provided in the context of a particular application and its requirements.
Various
modifications to the preferred embodiments will be readily apparent to those
skilled in the art,
and the generic principles defined herein may be applied to other embodiments.
The present
invention is not intended to be limited to the embodiments shown, but is to be
accorded the
widest scope consistent with the principles and novel features disclosed
herein.
A discussion of the principles of non-invasive infrared spectrometry applied
to analyte
quantification can be found in the incorporated references.
The present invention teaches a method and apparatus for creating and
controlling the
magnitude, propagation, velocity, and contour profile of a thermal gradient,
and incorporates
cyclic cooling and rewarming of a sample observation site. Furthermore, the
present invention
5
CA 02385288 2002-03-20
WO 01/30236 PCT/LJS00/40785
teaches the detection and measurement of infrared spectral emissions from the
sample tissues.
Referring to Figure 1, a block diagram of an embodiment of the present
invention is
shown. The embodiment shown provides a solid-state thermal gradient inducing
device 500
for inducing a temperature gradient within a tissue sample 100. The infrared
emissions from
S the body are then transmitted through the thermal gradient device 500 where
they are collected
by an infrared radiation detector assembly 700. The detector assembly 700
receives the
infrared emissions from the tissue 100 and measures certain wavelength
information which is
passed on to a signal processing system 800 which processes the information.
The several
elements of the system will be described below.
The solid-state thermal gradient device 500 is comprised of three general
components:
An infrared transmissive window assembly 200 which provides direct contact
with a tissue
sample 100 permitting the transmission of infrared radiation from the tissue
sample to the IR
radiation detector assembly 700. The solid-state thermal gradient device 500
also includes a
means 300 for inducing a temperature gradient in the tissue sample 100. This
means 300
1 S typically includes a heating element and a cooling element. The heating
element may be
integral to the infrared transmissive window assembly 200. Finally, the solid-
state thermal
gradient device 500 incorporates a heat sink 400 which is in thermal
communication with the
cooling element.
Window Assembly 200
In one preferred embodiment of the present invention, as shown in Figure 2,
the solid-
state thermal gradient device 500 includes an infrared transmissive window
assembly 200. The
window assembly 200 includes a plurality of infrared transmissive elements
which may be
constructed in a layered fashion.
Figure 3 depicts a layered window assembly 200. The window assembly features
an
infrared transmissive thermally conductive spreader layer 205. Underlying the
spreader layer
205 is a heater or heating element 220. This heating element 220 can be
treated with a thin
electrically insulating layer (not shown). Adjacent to the heating element 220
is a thermal
insulating and impedance matching element 230. Adjacent to the thermal
insulating element
230 is a thermally conductive base layer 240. The thermally conductive
spreader layer 205 is
coated on its top surface with a thin layer of protective coating 201. The
bottom surface of the
6
CA 02385288 2002-03-20
WO 01/30236 PCT/US00/40785
base layer is coated with a thin overcoat layer 242. Preferably, protective
coating 201 and
overcoat layer 242 have antireflective properties.
The spreader layer 205 is preferably formed of infrared transmissive material
having
a high thermal conductivity sufficient to facilitate heat transfer from the
heater element 220
S uniformly into the tissue sample 100. A satisfactory material is silicon
crystal formed using
a float zone crystal growth method. A generalized discussion of this method of
silicon
fabrication may be found in Microchip Fabrication. A Practical Guide to
Semiconductor
Processing. 3rd Ed., Peter Van Zant, McGraw Hill 1997, which is hereby
incorporated by
reference. Other effective materials include, but are not limited to, chemical
vapor deposited
diamond, diamondlike carbon, gallium arsenide, germanium, and other IR
transmissive
materials having sufficiently high thermal conductivity. Preferred dimensions
for the spreader
layer 205 are about one inch in diameter and about 0.010 of an inch thick.
Figure 3 shows a
preferred embodiment of the spreader layer 205 with a beveled edge. Although
not required,
an approximate 45 ° bevel is preferred.
A protective layer 201 is formed on the top surface of the spreader layer 205.
The
protective layer is intended to protect the top surface of the spreader layer
205 from damage.
Ideally, the protective layer is highly resistant to mechanical damage, such
as scratching and
other abrasive forces. Additionally, the protective layer is infrared
transmissive. It is
particularly advantageous if the protective layer 201 is also optimized to
have antireflective
properties and to increase transmission of optical radiation in the wavelength
range of about
5 to 12 ~,. For example, when a float zone silicon is used as a spreader layer
205, the spreader
layer reflects 30% of the incident light at the air:silicon interface because
of the relatively high
refractive index of silicon. The protective layer 201 is designed to match the
refractive index
of tissue and reduce the surface reflectance of the spreader layer 205,
thereby optimizing the
amount of energy passing through the window assembly 200. The protective layer
201 must
also have high thermal conductivity. A satisfactory protective layer material
is a proprietary
multi-layer Broad Band Anti-Reflective Coating produced by Deposition Research
Laboratories, Inc. of St. Charles, Missouri. Diamondlike carbon coatings are
also
satisfactory.
Underlying the spreader layer 205 is a heating element 220. The heating
element 220
7
CA 02385288 2002-03-20
WO 01/30236 PCT/US00/40785
must also provide a maximum acceptable optical throughput and should be
electrically insulated
from the spreader layer substrate material. A preferred heating element 220
obscures about
% or less of the window assembly 200. Satisfactory heating elements include,
but are not
limited to, heat exchangers, electrical resistance heating grids, thermal
electric heaters, radio
5 frequency (RF) heaters, infrared radiation heaters, optical heaters, or wire
bridge heating
grids. Additionally, a doped infrared transmissive material with regions of
higher and lower
resistivity may be used. For example, a doped silicon layer may be used as a
heater.
One embodiment of such a heater element 220 is the heating grid shown in
Figure 4.
The embodiment shown in Figure 4 shows a metal heater grid 221 designed and
manufactured
10 by Deposition Research Laboratories, Inc. The heater grid 221 has a
resistance of about 2
ohms and has a preferred thickness of 1,500 A. A preferred grid material is a
gold alloy, but
other acceptable materials include, but are not limited to, platinum (Pt),
titanium (Ti), tungsten
(W), copper (Cu), and nickel (Ni). The perimeter of the grid is surrounded by
a bus bar 222
for contacting electrode leads. The heater 220 is covered with an electrically
insulating coating
IS which also enhances adhesion to the spreader layer 205. One preferred
covering is an
aluminum oxide (A1203) coating over the grid pattern to prevent electrical
current from
conducting through the spreader layer 205 into the tissue 100. A1203 also
advantageously
increases the adhesion of the heater element 220 to the spreader layer 205.
Other acceptable
materials include, but are not limited to, titanium dioxide (TiOz) or zinc
selenide (ZnSe). The
heater grid 221 is electrically connected to an electrical power source
through the bus 222. A
preferred bus bar material is gold. One preferred example of a heater grid
incorporates a
variable pitch distance "d" between the conducting lines to maintain a
constant power density
across the entire grid 221. In this embodiment a preferred line width "w" is
about 25 microns.
Another design for maintaining a constant power density across the entire grid
221
incorporates varying line widths "w" while keeping the pitch distance "d"
constant.
Referring again to Figures 2 and 3, underlying the heater 220 is a thermal
insulating
layer 230. The thermal insulating layer 230 serves several novel and
surprising functions
which will be discussed in more detail below. The thermal insulating layer 230
prevents the
dissipation of heat from the heater element 220 while allowing the cold from a
cooling element
(not shown) to effectively cool the tissue 100. The thermal insulating layer
230 is comprised
8
CA 02385288 2002-03-20
WO 01/30236 PCT/US00/40785
of a material having thermally insulative (e.g., lower thermal conductivity
than the spreader
layer) and infrared transmissive qualities. A preferred material is a
germanium arsenic
selenium compound of the calcogenide glass family known as AMTIR-1 produced by
Amorphous Materials, Inc. of Garland, Texas. A further description of this
material may be
found on that firm's material data safety sheet (MSDS). The pictured
embodiment has a
diameter of about 0.85 of an inch and a preferred thickness in the range of
about 0.005 to
about 0.010 of an inch. As the heating element 220 heats through the spreader
layer 205 into
the tissue 100, the thermal insulating layer 230 (having a low thermal
conductivity) insulates
this heat. Underlying the thermal insulating layer 230 is a base layer 240
which is formed of
thermally conducting material. A preferred material is crystalline silicon
formed using float
zone crystal growth. The purpose of this base layer 240 is to serve as a cold-
conducting
mechanical base for the entire layered window assembly. The bottom surface of
the base layer
is treated with an overcoat layer 242. The overcoat layer 242 is preferably a
proprietary multi-
layer Broad Band Anti-Reflective Coating optimized for the transmission of
radiation in the
IS wavelength range between about 5 to about 12 ~. and having the refractive
index of air. Such
coating materials are available from Deposition Research Laboratories, Inc. in
St. Charles,
Missouri.
The overall optical transmission of the layered window assembly 200 is equal
to or
greater than 70 % . The layered window assembly 200 is held together and
secured to the
gradient device 500 by a holding bracket. The bracket is preferably formed of
a glass-filled
plastic, for example, Ultem 2300, manufactured by General Electric. The Ultem
2300 has a
low thermal conductivity which insulates the heat transfer from the layered
window assembly
200. As such, the tissue 100 is solely heated and cooled by the heat and cold
emanating from
the layered window assembly 200.
Referring to Figure 5, a portion of the entire solid-state non-invasive device
for
determining analyte concentration in sample tissues is shown. The layered
window assembly
200 is depicted as resting above a cold reservoir 330 which is adjacent to the
cooling element
350. The cooling element 350 may be selected from such elements as air cooled
convection
coolers, passive conduction coolers, such as heat sinks, or active conduction
coolers, such as,
thermal electric coolers. The cooling element 350 may be also selected from
the group of
9
CA 02385288 2002-03-20
WO 01/30236 PCT/CTS00/40785
cooling elements including, but not limited to, water baths, gas coolers using
cold 1V2 or other
gases, or infrared transmissive cooling fluids. The preferred cooling element
is a thermal
electric cooler, for example, a 25 W thermal electric cooler manufactured by
Melcor in
Trenton, New Jersey. The cooling element 350 (hereinafter referred to as
"thermal electric
cooler" or "TEC ") is positioned in thermal contact with the cold reservoir
330. A preferred
cold reservoir 330 is a copper ring structure which is in thermal contact with
both the layered
window assembly 220 and the TEC 350.
It is the combination of the heating element 220, the thermal insulating
element 230,
the cold reservoir 330, and the cooling element 350 that comprises a means for
inducing a
temperature gradient in the tissue 100. Typically, this is accomplished by
setting the cooling
element 350 to a constant temperature of in the range of about 8-15°C.
The heating element
220 is then cyclically activated to heat to a maximum of about 40°C.
Thermal cycling the
heating element 220 cyclically heats the layered window assembly 200 and
induces a
temperature gradient in the tissue 100.
With continuing reference to Figure 5, the inventors discovered that when a
thermal
electric cooler is chosen as the cooling element 350, a certain amount of
waste heat builds up
in the gradient device 500. In order to stabilize the operational temperature
of the device, a
heat sink 400 is in thermal communication with the TEC 350. The heat sink 400
effectively
bleeds off the waste heat from the TEC 350, enabling the device 500 to
function within a
constant temperature range. Furthermore, the heat sink may have cooling fins
410 to enhance
the cooling effectiveness of the heat sink 400. Additionally, the heat sink
400 features a cavity
420. The cavity may be filled with a phase change material 430 (not shown) to
enhance the
temperature stabilizing effect of the heat sink 400. A phase change material
430 as defined
herein is any material which undergoes a temperature dependent change of
phase. For
example, water undergoes a phase change from ice to water. In the process of
undergoing the
phase change, such materials absorb a great deal of heat, thereby enhancing
the effectiveness
of the heat sink 400. A preferred phase change material 430 is a hydrated
salt, such as calcium
chloride hexahydrate. A proprietary version of this material, TH29, is
produced by Phase
Change Solutions, of Naperville, Illinois. Further description of this
material is included in
that firm's MSDS which is incorporated by reference. This material has a
melting point of
CA 02385288 2002-03-20
WO 01/30236 PCT/LTS00/40785
29°C, which is close to the working temperature of the device. The
effectiveness of this phase
change material 430 is clearly demonstrated in Figure 6, which is a graph of
temperature
stability over time with the instrument operating normally. The temperature
stability, over
time, of a heat sink using TH29 610 has superior temperature stability
performance than both
water 620 and a heat sink 400 with no phase change material 630.
The ability of the gradient inducing means is further enhanced by the presence
of the
thermal insulating layer 230 of the layered window assembly 200. The thermal
insulating layer
230 is positioned between the heating element 220 and the base 240. It was
discovered by the
inventors that, in the absence of the insulating element 230, the cold from
the cooling element
350 excessively reduced the temperature of the heating element 220. This led
to difficulties
in repeating. In order to sufficiently rewarm the heating element 220 after
such cooling, a
great deal of power was required. Furthermore, the time required to heat the
cooling element
220 to operational temperature prohibitively restricted the cycle time.
Therefore, in an effort
to increase the rate of heating and cooling and increase cycle time, a
thermally insulating
IS element 230 was added. The presence of the insulating element 230 helps the
heating element
220 to maintain a consistent and relatively high temperature, thereby making
it possible to
repeat the heating element 220 and spreader layer 205 and, consequently, the
tissue 100 more
quickly. Of equal importance the insulating element makes repeating possible
using less
power. These factors make quicker cycle times possible. The surprising result
is that the
presence of the insulating layer 230 does not significantly inhibit the
cooling effects of the TEC
350. Therefore, the gradient inducing means (i.e. the heating element 220, the
thermally
insulating element 230, and the cooling element 350) are substantially
enhanced in their
effectiveness by the presence of the thermally insulating layer 230.
The layered window assembly 200 is designed with the idea of transmitting the
maximum amount of optical energy through the window 200. Furthermore, the cold
reservoir
330, the thermal cooling element 350, and heat sink 400 are all designed to
minimally obstruct
the transmission of optical radiation. Positioned beneath the layered window
assembly 200 is
an infrared radiation detector assembly 700.
With reference to Figures 5 and 7, a particular embodiment of the infrared
radiation
detector 720, which forms a part of the infrared radiation detector assembly
700, is shown.
11
CA 02385288 2002-03-20
WO 01/30236 PCT/US00/40785
It should be pointed out that many different types of radiation detectors may
be utilized
including, but not limited to, interferometers, spectrophotometers, grating
monochromators,
variable filter monochromators, and groups of discrete infrared bandpass
filters (or Fabry-
Perot filters, including tunable Fabry-Perot filters) and detectors. The
effectiveness of said
infrared radiation detector assembly 700 may be enhanced by the presence of a
high reflectance
scrambler 710. The scrambler 710 is designed to randomize the directionality
of radiation
which enters the layered window assembly 200. The scrambler 710 effectively
minimizes the
effect of tissue irregularities thereby maximizing the detectable signal. The
scrambler 710 is
either made from, or coated with, a material which does not preferentially
absorb optical
radiation in the range of about 5 p to about 12 ~,. A satisfactory scrambler
710 may be
constructed having an electroform gold layer. A satisfactory high reflectivity
gold electroform
optical scrambler 710 is manufactured by Epner Technology, of Brooklyn, New
York. At the
exit of the scrambler 712 lies a detector element 720. As explained above, the
detector element
720 may be selected from among many suitable devices. One preferred embodiment
uses a
IS series of bandpass filters 720F having an underlying series of radiation
detectors 720D.
One embodiment uses several bandpass wavelengths optimized to detect the
presence
of a glucose analyte in a tissue sample. Glucose has several strong and
distinguishing
absorption peaks between 9 and 10 microns; meaning the transmission of optical
energy
through glucose drops significantly in this wavelength range. As the infrared
energy naturally
emitted by the inner tissue passes through the glucose in the outer layers of
the tissue, some
of the energy in the 9.3 micron to 9.6 micron bands is absorbed.
At these particular wavelengths where glucose absorbs strongly, most energy
originating deep within the tissue is absorbed before it reaches the surface .
At other
wavelengths where glucose is only weakly absorbent, a larger amount of energy
from deep
within the tissue fords its way to the surface. Additionally, at wavelength
ranges where
glucose doesn't absorb, for example about 8-9 microns, a reference signal
which may be used
for the differentiation of glucose, may be measured. Thus, the large magnitude
and specificity
of the glucose absorption peaks allows the differentiation of glucose from
other interfering
substances.
Because the human body is comprised mostly of water, it is necessary to
differentiate
12
CA 02385288 2002-03-20
WO 01/30236 PCT/US00/40785
the smaller amount of glucose present in the larger concentration of water in
the human body.
Water absorbs far- and mid-wavelength infrared energy at most wavelengths.
However, a
infrared transmission "window" exists, in which infrared energy is not
completely absorbed.
This "window" allows analysis of the 9.3 to 9.6 micron glucose absorption
bands because this
region of substantially reduced water absorption is the same region in which
glucose strongly
absorbs. Also, more specifically, in the wavelength range of about 10-11
microns, neither
water nor glucose biological substances absorbs strongly. Therefore, this
wavelength range
may also provide reference wavelengths for both water and glucose, allowing
their
differentiation.
On the other hand, the wavelength ranges where water strongly absorbs can be
used to
determine the absorbance of the target tissue and, therefore, the surface
radiation. For
example, wavelengths in the range of about 5.9-6.2 microns, may be used to
quantify water.
Additionally, in the range of about 11.5-13 microns, strong and distinct water
absorption peaks
exist, providing ideal wavelengths for analyzing the tissue surface
absorption.
IS Other wavelength ranges can be examined. They enhance the ability of the
device to
differentiate non-water, non-glucose effects in the tissue. For example,
radiation has maximum
tissue penetration in the 5.0-5.5 wavelength range. Therefore, information
about the maximum
analytical tissue depth can be obtained in this range where neither IIzO nor
biological
constituents absorb. Some proteins and some glycosylated proteins are an
examples of a
significant class of interfering substances which interfere with the accurate
measurement of
glucose in blood. Because these proteins have major absorption peaks about the
(6.2-6.6) and
(7.9-8.1), and (9-10) micron wavelength ranges, they can be isolated and
compensated for.
In addition, an appropriate reference signal for protein can be measured
outside of these
ranges, for example, at about 8.2 or 8.3 microns.
Different filter combinations can be optimized to detect other interfering
analytes as
well. In addition to glycosylated proteins, other materials may be compensated
for. Examples
of other interfering substances include, but are not limited to, Vitamin C,
acetaminophen,
alcohol, and urea.
One preferred embodiment, optimized to detect the presence of a glucose
analyte in a
tissue sample, uses eight filters 720F having the following bandpass
wavelengths: 6.1~,, 6.9~,
13
CA 02385288 2002-03-20
WO 01/30236 PCT/US00/40785
8.S~c, 9.3~,, 9.7~,, 10.4., 11.0,, and 12.5 ~. Filter combinations using a
fewer number or
different filters may be used. Satisfactory filters may be obtained from
Optical Coating
Laboratory, Inc. (OCLI) of Santa Rosa, California. It is contemplated that in
accordance with
the principles of the present invention, other filters or filter combinations
optimized to detect
S other analytes may be used. Also, other detection methods or devices are
contemplated by the
present invention. The filtered radiation can be detected by a plurality of
detectors 720D, for
example, an array of Photo Voltiac Mercury Cadmium (PVMCT) detectors.
Satisfactory
detectors may be obtained from FERMIONICS of Simi Valley, California, for
example, PV-
9.1 detectors with PVA-481-1 preamplifiers may be used. Custom thermal boards
produced
by Optiscan may be used to control temperatures of the detector and the
infrared transmissive
window assembly. Similar units available from other manufacturers may also be
used.
Additionally, room temperature micro-bolometers can be used. These detectors
produce an
electronic signal which is passed on to a signal processing system 800. Custom
circuit boards
produced by Optiscan may be used to control temperatures of the detector and
the infrared
IS transmissive window assembly. Similar units available from other
manufacturers may also be
used.
A satisfactory signal processing system 800 is a general purpose programmable
personal computer commonly available from companies such as an IBM, Dell,
Gateway, etc.
Numerous other computers or data processing devices may be used with equal
facility.
Furthermore, a specialized computer, implemented as hardware, firmware,
software or a
combination thereof could be devised to accomplish the needed signal
processing functions.
The computer provides a computational engine, display and user interface. An
analog-to
digital (A/D) system may be used to convert analog detector signals to
appropriate computer
input signals. For example, an acceptable A/D converter is a "PCI-MIO-16XE10"
manufactured by National Instruments of Austin, Texas.
It will be appreciated that many modifications can be made to the embodiments
described above without departing from the spirit and the scope of the
invention.
In particular, it should be noted that many different phase change materials
may be used
in conjunction with the heat sink as can many different layered window
assemblies. Also, if
bandpass filters are used in conjunction with the infrared detector, many
different filters may
14
CA 02385288 2002-03-20
WO 01/30236 PCT/US00/40785
be used and said filters may be optimized to detect analytes other than
glucose.
The present invention has been particularly shown and described with respect
to certain
preferred embodiments and the features thereof. It is to be understood that
the shown
embodiments are the presently preferred embodiments of the present invention
and, as such,
are representative of the subject matter broadly contemplated by the present
invention. The
scope of the invention fully encompasses other embodiments which may become
obvious to
those skilled in the art, and are accordingly to be limited by nothing other
than the appended
claims, in which reference to an element in the singular is not intended to
mean "one and only
one" unless explicitly stated, but rather "one or more". All structural and
functional
equivalents of the elements of the above-described preferred embodiments that
are known or
later come to be known to those of ordinary skill in the art are expressly
incorporated herein
by reference and are intended to be encompassed by the present claims.
Moreover, it is not
necessary for a device or method to address each and every problem solved by
the present
invention, for it to be encompassed by the present claims. Furthermore, no
element,
IS component, or method step in the present disclosure is intended to be
depicted to the public
regardless of whether the element, component, or method step is explicitly
recited in the
claims. No claim element herein is to be construed under the provisions of 35
U.S.C. ~ 112,
paragraph 6, unless the element is expressly recited using the phrase "means
for".
